Clinical trial Recruiting at 1 site Phase 1 Interventional Ages 18 to 80

Using sodium bicarbonate to change 24-hour urine measurements in people with low urine citrate or uric acid kidney stones

Official title: Impact of Sodium Bicarbonate on 24-hour Urine Parameters in Hypocitriuric and Uric Acid Stone Formers

Run by University of California, Irvine · NCT06335537 · Data updated 2026-11-12

This will see if taking sodium bicarbonate instead of potassium citrate changes 24-hour urine measurements in adults with low urine citrate or uric acid kidney stones.

More Uric Acid trials

Quick facts

PhasePhase 1
Study typeInterventional
Ages18 Years to 80 Years
SexAll
Enrollment100 (estimated)
SponsorUniversity of California, Irvine
Academic / other
Locations1 site (Orange, California)
StatusRecruiting
StartedMay 1, 2025
Main results expectedJuly 2026
Study endsJuly 2026
Registry record updatedJune 24, 2025
Trial IDNCT06335537 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–79 who form calcium oxalate or uric acid stones, have low urine citrate (<320 mg/24 h), are currently taking Urocit-K, and do not have excluded conditions like reduced kidney function, diabetes, pregnancy, or certain GI/metabolic disorders.

Probably not a fit

Patients with impaired kidney function (eGFR <60), active diabetes, pregnancy or breastfeeding, those on thiazides or ACE inhibitors, or people whose stones are not related to low citrate or acidic urine are unlikely to benefit from this approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This Phase 1 interventional study at the University of California, Irvine will switch eligible adults from potassium citrate (Urocit-K) to sodium bicarbonate and measure changes in 24-hour urine chemistry. Participants are adults with hypocitraturia (<320 mg/24 h) who form calcium oxalate or uric acid stones and are already on Urocit-K. The trial compares urinary citrate, urine pH, and other 24-hour urine parameters before and after the intervention. The protocol excludes people with reduced kidney function, diabetes, certain GI or metabolic disorders, pregnancy, or those taking thiazides or ACE inhibitors.

Why it matters

Potential benefit: If successful, sodium bicarbonate could offer a lower-cost alternative to potassium citrate to improve urine chemistry and lower stone recurrence risk.

How similar studies have gone: Potassium citrate is well established to raise urinary citrate, but substituting sodium bicarbonate as a lower-cost alternative has been less studied and remains relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* \> 18 years of age and \< 80 years of age,
* Hypocitriuric (\<320 mg/24 hours), Calcium Oxalate Stone or Uric Acid stone formers, currently on Urocit-K therapy as the standard of care.

Exclusion Criteria:

* Male or female \<18 years old or \> 80 years old.
* Currently taking thiazides or ACE inhibitor medications
* Pregnant women.
* Women who are breastfeeding or plan to breastfeed during study period
* History of abnormal renal function (defined as eGFR \<60 mL/min/1.73 m2), active urinary tract infection, diabetes, cystinuria, renal tubular acidosis, inflammatory bowel disease, chronic diarrhea, primary hyperparathyroidism, peptic ulcer disease.

Where it's running

  • University of California, Irvine Medical Center
    Orange, California, United States
    Recruiting

Study contacts

  • Principal investigator: Sohrab N Ali, M.D — University of California, Irvine
  • Study coordinator: Sohrab N Ali, M.D
  • Email: sohrabna@hs.uci.edu
  • Phone: 7145062352

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.